M. Ashawat

Integrating Artificial Intelligence with Liposomal Nanocarriers for Advanced Drug Delivery.

INTRODUCTION Liposomal drug delivery systems have achieved notable clinical success; however, their wider translation is often limited by complex formulation variables, unpredictable process behavior, and scalability challenges. Traditional trial-and-error optimization strategies struggle to address the nonlinear relat...

Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects.

APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape.

Repurposing apremilast for alzheimer’s disease: multitarget modulation of cAMP‑PI3K/Akt–GSK‑3β and NF‑κB signaling

Current mechanistic evidence supporting apremilast as a potential multitarget repurposing candidate in AD is synthesized, thereby addressing key knowledge gaps in the current literature.

From glycemic control to neuroprotection: alogliptin as a repurposed candidate for Huntington’s disease

This narrative review critically evaluates the available experimental evidence supporting the repurposing potential of Alogliptin for HD and identifies alogliptin as a potent repurposable agent and the necessity to conduct specific experimental and clinical research to determine its effectiveness.